MedPath

self-management program in patients with mechanical heart valve

Phase 2
Conditions
mechanical heart valve patients.
Presence of prosthetic heart valve
Registration Number
IRCT201406154443N13
Lead Sponsor
Vice chancellor for research of Tehran University of Medical Scinces
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
88
Inclusion Criteria

The use of warfarin as an anticoagulant; The patient or the patient's immediate family members are not members of the treatment team; having 18-60 years old; Doesn’t be under another study; having heart valve replacement surgery in recent year for the first time; Doesn’t have chronic disease; Doesn’t have mental disorder. Exclusion criteria: During the study, patients had a complications of drug abuse; Wouldn’t like to continue; Wouldn’t like to continue intervention followed with telephone contacts.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Drug adherence. Timepoint: before and 8 weeks after intervention. Method of measurement: drug adherence questionnaire and INR test.;Self-efficacy. Timepoint: before and 8 weeks after intervention. Method of measurement: self-efficacy questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath